Skip to content
Open Data Finder
Open Government Canada

Notice: Prescription Drug List (PDL): Triamcinolone acetonide

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.

Notice: Prescription Drug List (PDL): Triamcinolone acetonide · Open Data Finder